EUVIMEDEUVIMED entdecken
Crossref

Development of a Preterm Birth Risk Prediction Model Based on CCL28 Biomarker Selection and Multidimensional Data Integration

Yingying Li iD, Ning Xu, Jie Zhang, Guocheng Liu

American Journal of Reproductive Immunology · 2025

DOI: 10.1111/aji.70175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Yingying Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Premature Birth, Biomarkers, Chemokines, CC, Placenta. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Clinical Research Project of Guangdong Women and Children Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study aimed to identify potential biomarkers for preterm birth (PTB) and construct a multidimensional risk prediction model integrating clinical and proteomic data, with a focus on CCL28. Materials and Methods Pregnant women were enrolled and categorized into PTB and term birth (TB) groups. Plasma and placental samples were analyzed using OLINK proteomics, ELISA, and immunohistochemistry. Logistic regression and nomogram modeling were employed to assess predictive markers, while ROC curve analysis was used to evaluate model performance.

Results

Proteomic analysis revealed significantly lower CCL28 levels in PTB compared to TB ( p < 0.01), which was validated by ELISA ( p < 0.0001). Immunohistochemistry confirmed reduced CCL28 expression in PTB placental tissue. Multivariate logistic regression identified CCL28 as an independent predictor of PTB (OR = 0.150, p = 0.01). The developed nomogram, incorporating CCL28 levels and clinical variables, demonstrated strong predictive ability (AUC = 0.841).

Conclusion

CCL28 was identified as a key biomarker for PTB prediction. The integrated prediction model enhanced early risk assessment, providing a valuable tool for targeted clinical interventions in high‐risk pregnancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Premature BirthBiomarkersChemokines, CCPlacentaHumansFemalePregnancyAdultNomogramsRisk AssessmentProteomics

Stichwörter der Autor:innen

CCL28biomarkersnomogrampredictive modelingpreterm birthproteomics

Substanzen

BiomarkersChemokines, CC

Autor:innen und Institutionen

  • Guangzhou Medical University, Guangzhou, China.
  • Department of Rehabilitation, Guangdong Women and Children Hospital, Guangzhou, China.
  • Department of Obstetrics, Guangdong Women and Children Hospital, Guangzhou, China.

ORCID-Profile: Yingying Li

Förderung

  • Clinical Research Project of Guangdong Women and Children Hospital

Zitieren

APA

Li, Y., Xu, N., Zhang, J., & Liu, G. (2025). Development of a Preterm Birth Risk Prediction Model Based on CCL28 Biomarker Selection and Multidimensional Data Integration. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70175

Vancouver

Li Y, Xu N, Zhang J, Liu G. Development of a Preterm Birth Risk Prediction Model Based on CCL28 Biomarker Selection and Multidimensional Data Integration. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70175

BibTeX
@article{Li2025,
  author = {Li, Yingying and Xu, Ning and Zhang, Jie and Liu, Guocheng},
  title = {Development of a Preterm Birth Risk Prediction Model Based on CCL28 Biomarker Selection and Multidimensional Data Integration},
  journal = {American Journal of Reproductive Immunology},
  year = {2025},
  doi = {10.1111/aji.70175}
}
Kostenlos starten →